Gene · 571
Papers2,758
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,758
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sinensetin protects against periodontitis through binding to Bach1 enhancing its ubiquitination degradation and improving oxidative stress. | Int J Oral Sci | 2024 | 38734708 | PubTator, text mining | PubMed |
| PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer. | Cell Rep | 2024 | 38691454 | PubTator, text mining | PubMed |
| TANK Binding Kinase 1 Promotes BACH1 Degradation through Both Phosphorylation-Dependent and -Independent Mechanisms without Relying on Heme and FBXO22. | Int J Mol Sci | 2024 | 38673728 | PubTator, text mining | PubMed |
| Spatial organization and functions of Chk1 activation by TopBP1 biomolecular condensates. | Cell Rep | 2024 | 38578830 | PubTator, text mining | PubMed |
| Single-Nucleus Multiomic Analyses Identifies Gene Regulatory Dynamics of Phenotypic Modulation in Human Aneurysmal Aortic Root. | Adv Sci (Weinh) | 2024 | 38552156 | PubTator, text mining | PubMed |
| Cross-Omic Transcription Factor Analysis: An Insight on Transcription Factor Accessibility and Expression Correlation. | Genes (Basel) | 2024 | 38540327 | PubTator, text mining | PubMed |
| Combining bulk and scRNA-seq to explore the molecular mechanisms governing the distinct efferocytosis activities of a macrophage subpopulation in PDAC. | J Cell Mol Med | 2024 | 38501838 | PubTator, text mining | PubMed |
| Treatment with siRNAs is commonly associated with GPX4 up-regulation and target knockdown-independent sensitization to ferroptosis. | Sci Adv | 2024 | 38489367 | PubTator, text mining | PubMed |
| Identification of BACH1-IT2-miR-4786-Siglec-15 immune suppressive axis in bladder cancer. | BMC Cancer | 2024 | 38468240 | PubTator, text mining | PubMed |
| Bile acids inhibit ferroptosis sensitivity through activating farnesoid X receptor in gastric cancer cells. | World J Gastroenterol | 2024 | 38414591 | PubTator, text mining | PubMed |
| Genetic associations with ratios between protein levels detect new pQTLs and reveal protein-protein interactions. | Cell Genom | 2024 | 38412862 | PubTator, text mining | PubMed |
| Interactions between zinc and NRF2 in vascular redox signalling. | Biochem Soc Trans | 2024 | 38372426 | PubTator, text mining | PubMed |
| Transcription factor BACH1 in cancer: roles, mechanisms, and prospects for targeted therapy. | Biomark Res | 2024 | 38321558 | PubTator, text mining | PubMed |
| MoDAFold: a strategy for predicting the structure of missense mutant protein based on AlphaFold2 and molecular dynamics. | Brief Bioinform | 2024 | 38305456 | PubTator, text mining | PubMed |
| Carbamate compounds induced toxic effects by affecting Nrf2 signaling pathways. | Toxicol Rep | 2024 | 38304697 | PubTator, text mining | PubMed |
| Editorial: Transcriptional regulation in cardiovascular diseases. | Front Cardiovasc Med | 2024 | 38298758 | PubTator, text mining | PubMed |
| Single nuclei transcriptomics in human and non-human primate striatum in opioid use disorder. | Nat Commun | 2024 | 38296993 | PubTator, text mining | PubMed |
| Targeting FBXO22 enhances radiosensitivity in non-small cell lung cancer by inhibiting the FOXM1/Rad51 axis. | Cell Death Dis | 2024 | 38296976 | PubTator, text mining | PubMed |
| Effects of N6-methyladenosine modification on metabolic reprogramming in digestive tract tumors. | Heliyon | 2024 | 38293446 | PubTator, text mining | PubMed |
| Pyroptosis-Related Gene Signature Predicts Prognosis and Response to Immunotherapy and Medication in Pediatric and Young Adult Osteosarcoma Patients. | J Inflamm Res | 2024 | 38269108 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/571/papers?page=11